Results 21 to 30 of about 973,470 (302)

Interleukin-16 [PDF]

open access: yesJournal of Leukocyte Biology, 1997
Abstract Interleukin 16 (IL-16) was initially described in 1982 as the first T cell chemoattractant. Through interaction with CD4, IL-16 has now been characterized as a chemoattractant for a variety of CD4+ immune cells. Recent in vivo studies have more fully characterized IL-16 as an immunom  odulatory cytokine that contributes to the ...
W W, Cruikshank   +2 more
openaire   +3 more sources

Investigating Histological Changes and Gene Expression of Interleukin-8, Interleukin-12, and Interferon Beta in Liver Tissue After Consumption of Lactobacillus rhamnosus GG Probiotic in Steatosis Model Rats [PDF]

open access: yesArmaghane Danesh Bimonthly Journal, 2022
Background & aim: Probiotic consumption can regulate the homeostasis of the digestive system and control metabolic diseases related to the digestive system. Therefore, the purpose of the present study was to determine and investigate histological changes
F Rostamkhani
doaj  

The cytokine milieu of bullous pemphigoid: Current and novel therapeutic targets

open access: yesFrontiers in Medicine, 2023
Bullous pemphigoid (BP) is the most common autoimmune bullous disease, characterized by severe pruritus and skin blistering. The loss of tolerance against Collagen XVII, also referred to as BP180, is the main pathogenic event of BP, leading to production
Roberto Maglie   +6 more
doaj   +1 more source

Interleukin-18 [PDF]

open access: yes, 2003
Interleukin-18 (IL-18), a recently described member of the IL-1 cytokine superfamily, is now recognized as an important regulator of innate and acquired immune responses.
McInnes, I.B.   +2 more
core   +1 more source

Activation of Gingival Fibroblasts by Bacterial Cyclic Dinucleotides and Lipopolysaccharide

open access: yesPathogens, 2020
Human gingival fibroblasts (HGFs) recognize microbe-associated molecular patterns (MAMPs) and respond with inflammatory proteins. Simultaneous impacts of bacterial cyclic di-guanosine monophosphate (c-di-GMP), cyclic di-adenosine monophosphate (c-di-AMP),
Samira Elmanfi   +5 more
doaj   +1 more source

Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies [PDF]

open access: yes, 2012
BACKGROUND: Persistent inflammation has been proposed to contribute to various stages in the pathogenesis of cardiovascular disease. Interleukin-6 receptor (IL6R) signalling propagates downstream inflammation cascades.
Thomas, GN   +492 more
core   +1 more source

Analysis of Lymphocyte Subsets Including Th17 Cells in Alcoholic Liver Disease [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2017
Introduction: Alcoholic Liver Disease (ALD), which consists of three major diseases: (1) fatty liver, (2) alcoholic hepatitis and (3) cirrhosis, is described to be associated with lymphopenia and an altered ratio of lymphocyte subsets but the reported
BIDYUT BIKASH GOGOI   +5 more
doaj   +1 more source

cDNA Cloning of Biologically Active Chicken Interleukin-18 [PDF]

open access: yes, 2000
By searching a chicken EST database, we identified a cDNA clone that appeared to contain the entire open reading frame (ORF) of chicken interleukin-18 (ChIL-18).
Stäheli, Peter   +15 more
core   +1 more source

Human mid-gestation amniotic fluid contains interleukin-16 bioactivity [PDF]

open access: yes, 2009
CD4-positive cells are detectable in the human fetal gastrointestinal tract from 11 weeks of gestation. Interleukin-16 (IL-16) is a chemoattractant for CD4(+) cells and, via fetal swallowing of amniotic fluid, could mediate the influx of CD4(+) cells ...
Warner, J.   +17 more
core   +1 more source

Truncated Chicken Interleukin-1β with Increased Biologic Activity [PDF]

open access: yes, 2003
Chicken interleukin-1β (ChIL-1β) is synthesized as a precursor molecule that unlike its mammalian counterpart, lacks a typical caspase-1 cleavage site. Therefore, it was unclear if proteolytic cleavage of ChIL-1β can occur and if cleavage might modulate ...
Erno Duda   +10 more
core   +1 more source

Home - About - Disclaimer - Privacy